White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy
Boulouis, Bricout, Benhassen, Ferrigno, Turc, Bretzner, Benzakoun, Seners, Personnic, Legrand, Trystram, Rodriguez-Regent, Charidimou, Rost, Bracard, Cordonnier, Oppenheim, Naggara, Henon (2019) White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy Neurology (IF: 9.9) 93(16) e1498-e1506
Full text
Click the PDF icon to view the full text of the paper
Abstract
To determine the influence of white matter hyperintensity (WMH) burden on functional outcome, rate of symptomatic intracerebral hemorrhage (sICH), and procedural success in patients with acute ischemic stroke (AIS) treated by mechanical thrombectomy (MT) with current stentriever/aspiration devices.Patients with AIS due to large vessel occlusion (LVO) from the Thrombectomie des Artères Cérébrales (THRACE) trial and prospective cohorts from 2 academic comprehensive stroke centers treated with MT were pooled and retrospectively analyzed. WMH volumes were obtained by semiautomated planimetric segmentation and tested in association with the rate of favorable outcome (90-day functional independence), substantial recanalization after MT, and sICH.A total of 496 participants were included between 2015 and 2018 (50% female, mean age 68.1 ± 15.0 years). Overall, 434 (88%) patients presented with detectable WMH (mean ± SD 4.93 ± 7.7). Patients demonstrated increasingly worse outcomes with increasing WMH volumes (odds ratio [aOR]1.05 per 1-cm3 increase for unfavorable outcome, 95% confidence interval [CI] 1.01-1.06, p = 0.014). Fifty-seven percent of patients in the first quartile of WMH volume vs 28% in the fourth quartile demonstrated favorable outcome (p < 0.001). WMH severity was not associated with sICH rate (aOR 0.99, 95% CI 0.93-1.04, p = 0.66), nor did it influence recanalization success (aOR 0.99, 95% CI 0.96-1.02, p = 0.84).Our study provides evidence that in patients with AIS due to LVO and high burden of WMH as assessed by pretreatment MRI, the safety and efficacy profiles of MT are similar to those in patients with lower WMH burden and confirms that they are at higher risk of unfavorable outcome. Because more than a quarter of patients in the highest WMH quartile experienced favorable 3 months outcome, WMH burden may not be a good argument to deny MT.NCT01062698.© 2019 American Academy of Neurology.
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815208http://www.ncbi.nlm.nih.gov/pubmed/31519778
http://dx.doi.org/10.1212/WNL.0000000000008317
